Focal therapy with low dose rate brachytherapy for localized prostate cancer

Focal therapy with low dose rate brachytherapy for localized prostate cancer - Focal brachytherapy for prostate cancer

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015071

Enrollment

200

Registered

2014-09-08

Start date

2014-09-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Localized prostate cancer

Interventions

Brachytherapy

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1) adenocarcinoma 2) prostate specific antigen 20 ng/ml or lower

Exclusion criteria

Exclusion criteria: 1) poor performanse status 2) severe comorbidity 3) transurethralresection of prostatectomy(TURP)

Design outcomes

Primary

Measure	Time frame
adverse events, urinary function, sexial function, recurrence-free survival	—

Secondary

Measure	Time frame
overall survival, disease-specific survival	—

Countries

Japan

Contacts

Public ContactShohei Fukuda

Institute of Science Tokyo Urology

shouro@tmd.ac.jp03-5803-5295

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026